Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	actin binding	PHACTR2 MYO1E MYO5A PXK FGD4 TBC1D21 EVL COBLL1 SORBS1 SHROOM2 SPATA32 XIRP2 INF2 SIPA1L1 MYO1F PARVA DAAM2 MYBPC1	6.50e-06	479	220	18	GO:0003779
GeneOntologyMolecularFunction	CTP binding	HSP90AA1 HSP90AB1	1.21e-04	2	220	2	GO:0002135
GeneOntologyCellularComponent	dendrite terminus	GPR179 CDKL5 HSP90AA1 HSP90AB1	5.34e-05	20	223	4	GO:0044292
Domain	CEBP_ZZ	CPEB2 CPEB3 CPEB4	6.66e-06	4	223	3	PF16366
Domain	RRM_7	CPEB2 CPEB3 CPEB4	6.66e-06	4	223	3	PF16367
Domain	CEBP_ZZ	CPEB2 CPEB3 CPEB4	6.66e-06	4	223	3	IPR032296
Domain	Fam133	FAM133A FAM133B	1.42e-04	2	223	2	IPR026766
Domain	SH3	MYO1E PRAM1 NGEF TJP2 SGSM3 SORBS2 SORBS1 TEC FRK MYO1F	2.80e-04	216	223	10	SM00326
Domain	SH3	MYO1E PRAM1 NGEF TJP2 SGSM3 SORBS2 SORBS1 TEC FRK MYO1F	2.80e-04	216	223	10	PS50002
Domain	SH3_domain	MYO1E PRAM1 NGEF TJP2 SGSM3 SORBS2 SORBS1 TEC FRK MYO1F	3.24e-04	220	223	10	IPR001452
Domain	SOHO	SORBS2 SORBS1	4.22e-04	3	223	2	PS50831
Domain	-	CLGN CALR	4.22e-04	3	223	2	2.10.250.10
Domain	TECPR	HERC2 TECPR1	4.22e-04	3	223	2	SM00706
Domain	Heat_shock_protein_90_CS	HSP90AA1 HSP90AB1	4.22e-04	3	223	2	IPR019805
Domain	SPAR_C	SIPA1L2 SIPA1L1	4.22e-04	3	223	2	PF11881
Domain	Sorb	SORBS2 SORBS1	4.22e-04	3	223	2	SM00459
Domain	CALRETICULIN_REPEAT	CLGN CALR	4.22e-04	3	223	2	PS00805
Domain	Sorb	SORBS2 SORBS1	4.22e-04	3	223	2	PF02208
Domain	SIPA1L_C	SIPA1L2 SIPA1L1	4.22e-04	3	223	2	IPR021818
Domain	Beta-propeller_rpt_TECPR	HERC2 TECPR1	4.22e-04	3	223	2	IPR006624
Domain	SoHo_dom	SORBS2 SORBS1	4.22e-04	3	223	2	IPR003127
Domain	SH3_1	MYO1E NGEF SGSM3 SORBS2 SORBS1 TEC FRK MYO1F	8.08e-04	164	223	8	PF00018
Domain	Hsp90_fam	HSP90AA1 HSP90AB1	8.38e-04	4	223	2	IPR001404
Domain	Hsp90_N	HSP90AA1 HSP90AB1	8.38e-04	4	223	2	IPR020575
Domain	HSP90	HSP90AA1 HSP90AB1	8.38e-04	4	223	2	PF00183
Domain	HSP90	HSP90AA1 HSP90AB1	8.38e-04	4	223	2	PS00298
Domain	Calret/calnex	CLGN CALR	8.38e-04	4	223	2	IPR001580
Domain	CALRETICULIN_1	CLGN CALR	8.38e-04	4	223	2	PS00803
Domain	CALRETICULIN_2	CLGN CALR	8.38e-04	4	223	2	PS00804
Domain	Calret/calnex_CS	CLGN CALR	8.38e-04	4	223	2	IPR018124
Domain	Calreticulin	CLGN CALR	8.38e-04	4	223	2	PF00262
Domain	WH2	PXK COBLL1 INF2	8.38e-04	16	223	3	PF02205
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TNIK KIZ RPS6KB1 NUBP1 PHF8 ARHGEF11 DDB1 LENG8 GRK2 ALMS1 NFKB1 TJP2 NKAP HERC2 SIPA1L2 DYNC1H1 PRRC2B HSP90AA1 FHIP2B ANKS1A HSP90AB1 SORBS1 KIAA1671 IGF2R TSR1 SIPA1L1 PRKCA CEP152	3.12e-12	853	228	28	28718761
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 NRIP1 ADAM19 MYO1E MYO5A CYTH1 TSPYL2 CMYA5 TUBGCP5 SETDB1 DIP2A PARP1 MTA3 NGEF C1S SGSM3 HERC2 DYNC1H1 HSP90AA1 HSP90AB1 USP13 SORBS2 JADE2 RBL2 ZNFX1 SORBS1 IDS SHROOM2 DROSHA SIPA1L1 CHMP3 DAAM2 METTL8 SEZ6L	4.90e-12	1285	228	34	35914814
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYO1E MYO5A ARHGEF11 DDB1 MECP2 NDUFS2 CDKL5 DIP2A PARP1 GRK2 FGD4 EIF3L NGEF TJP2 UQCRFS1 SIPA1L2 DYNC1H1 PRRC2B HSP90AA1 HSP90AB1 CPEB2 PITPNM2 EVL SORBS2 ZNFX1 SORBS1 SHROOM2 PRPF40A INF2 SIPA1L1 CPEB4 PRKCA EIF3A CTNND1	8.78e-11	1431	228	34	37142655
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NRIP1 EPS15 MYO5A KIZ RPS6KB1 TSPYL2 PTK7 KMT2C SLC8B1 MTA3 NGEF SEL1L3 ANKS1A FAM149A PITPNM2 COL5A1 EVL FUT10 JADE2 PORCN CCDC12 SKI SHROOM2 KIAA1671 HIVEP3 INF2 SBF2 RASGEF1C CTNND1 ZNF512 ERMARD	1.44e-08	1489	228	31	28611215
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	EPS15 MYO5A CYTH1 ERMP1 ARHGEF11 MECP2 TRIP4 NDUFS2 SCAF4 LENG8 KMT2C MTA3 FGD4 EIF3L NKAP UQCRFS1 HERC2 HEATR5B NRDE2 CHD7 SRBD1 KIAA1671 FAM133B TSR1 DROSHA SIPA1L1 MED25 EIF3A CDC42 ZHX1 EDRF1	1.63e-08	1497	228	31	31527615
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TNIK EPS15 MYO5A CYTH1 RPS6KB1 ARHGEF11 DDB1 PARP1 NGEF HERC2 DYNC1H1 PRRC2B HSP90AA1 ANKS1A HSP90AB1 SORBS2 ZNFX1 CHD7 SORBS1 AKAP12 IGF2R SIPA1L1 PRKCA CTNND1	2.65e-08	963	228	24	28671696
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 IL12RB2 TSPYL2 PHF8 TUBGCP5 DDB1 MECP2 TRIP4 ABCA8 SETDB1 MTA3 ALMS1 NKAP SIPA1L2 IQCM PRRC2B SMARCA5 SKI CHAMP1 PRPF40A KIAA1671 DROSHA SIPA1L1 CPEB4 SEZ6L	1.03e-07	1116	228	25	31753913
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	MYO1E MYO5A SKIDA1 MECP2 PARP1 MTA3 MKI67 TJP2 HERC2 DYNC1H1 HSP90AA1 HSP90AB1 CHD7 INF2 PRF1 SIPA1L1 CHMP3 CDC42	2.03e-07	626	228	18	33644029
Pubmed	12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression.	NFKB1 MMP9 PRKCA	2.78e-07	3	228	3	20458747
Pubmed	CPEB2, a novel putative translational regulator in mouse haploid germ cells.	CPEB2 CPEB3 CPEB4	2.78e-07	3	228	3	12672660
Pubmed	Systematic identification of factors for provirus silencing in embryonic stem cells.	SETDB1 MTA3 EIF3L TJP2 SMARCA5 AKAP12 TSR1 DNAAF10 EIF3A	8.40e-07	153	228	9	26365490
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PHACTR2 ELOA2 MYO5A SKIDA1 LYST MECP2 RYR2 PTK7 PARP1 UMODL1 EFCAB12 CC2D2A ABCC2 SIPA1L2 PRRC2B HSP90AA1 HSP90AB1 EVL SMARCA5 FAM133A SRBD1 SKI JSRP1 ADAMTS12 FAM133B EIF3A MYBPC1	1.05e-06	1442	228	27	35575683
Pubmed	Two previously undescribed members of the mouse CPEB family of genes and their inducible expression in the principal cell layers of the hippocampus.	CPEB2 CPEB3 CPEB4	1.11e-06	4	228	3	12871996
Pubmed	CPEB2-dependent translation of long 3'-UTR Ucp1 mRNA promotes thermogenesis in brown adipose tissue.	CPEB2 CPEB3 CPEB4	1.11e-06	4	228	3	30177570
Pubmed	Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.	NR1I2 NFKB1 NR1H3	1.11e-06	4	228	3	21245992
Pubmed	A directed protein interaction network for investigating intracellular signal transduction.	RPS6KB1 NUBP1 NDUFS2 KMT2C SETDB1 GRK2 EIF3L NGEF MKI67 SGSM3 HSP90AB1 SORBS2 CALR PRPF40A AKAP12 MIDN INF2 PARVA ROBO2 MAPK9 CDC42 ZHX1 EDRF1	1.62e-06	1124	228	23	21900206
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 MYO5A DDB1 EIF3L MKI67 TJP2 HERC2 DYNC1H1 PRRC2B COL5A1 SMARCA5 CALR CHD7 PRPF40A IGF2R TSR1 ZNF512	1.73e-06	653	228	17	22586326
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	CMYA5 DDB1 PARP1 GRK2 GLDC EIF3L POU2F3 ZNF714 HSP90AA1 HSP90AB1 SMARCA5 ZNF780B LARS2 TSR1	1.97e-06	451	228	14	36168627
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	TNIK SIPA1L2 PRRC2B EVL SORBS2 SORBS1 SIPA1L1 CPEB4 MYO1F CTNND1	1.99e-06	218	228	10	33378226
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TNIK MYO5A NDUFS2 RYR2 PTK7 CDKL5 GRK2 TJP2 SIPA1L2 HSP90AA1 HSP90AB1 PITPNM2 EVL SORBS2 ZNFX1 SORBS1 SHROOM2 AKR7A2 SIPA1L1 CPEB4 PRKCA CTNND1 CDC42	2.02e-06	1139	228	23	36417873
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	ARHGEF11 SETDB1 ALMS1 SORBS2 ZNFX1 SORBS1 SIPA1L1 CEP152	2.47e-06	130	228	8	12421765
Pubmed	A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons.	CPEB2 CPEB3 CPEB4	2.75e-06	5	228	3	20639532
Pubmed	Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes.	NR1I2 NFKB1 NR1H3	2.75e-06	5	228	3	20836841
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	PHF8 DDB1 MECP2 PARP1 MTA3 ZNF780A MKI67 HERC2 SMARCA5 CALR CHD7 SRBD1 CHAMP1 TSR1 ZNF512 ZHX1	3.07e-06	608	228	16	36089195
Pubmed	Characterization of hNek6 interactome reveals an important role for its short N-terminal domain and colocalization with proteins at the centrosome.	TRIP4 PRAM1 ERCC6L2 CDC42	4.00e-06	17	228	4	20873783
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TNIK EPS15 DDB1 SCAF4 LENG8 PARP1 ALMS1 MKI67 SIPA1L2 PRRC2B HSP90AA1 ANKS1A HSP90AB1 SMARCA5 CHAMP1 PRPF40A AKAP12 KIAA1671 EIF3A CTNND1	4.10e-06	934	228	20	33916271
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 MYO1E CYTH1 ARHGEF11 LYST KMT2C DIP2A SLC8B1 LRRC56 HERC2 SIPA1L2 DYNC1H1 PRRC2B PITPNM2 LRRK1 LARS2 HIVEP3 IGF2R MROH6 INF2 KLHL36 SBF2	4.27e-06	1105	228	22	35748872
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	TNIK MYO1E DDB1 MECP2 TRIP4 SCAF4 LENG8 PARP1 MKI67 TJP2 NKAP HERC2 DYNC1H1 PRRC2B HSP90AB1 NRDE2 SMARCA5 FAM133A COBLL1 CHD7 PRPF40A TSR1 DROSHA CPEB4 CTNND1	4.31e-06	1371	228	25	36244648
Pubmed	A human MAP kinase interactome.	ARHGEF11 LENG8 KMT2C SETDB1 HERC2 HSP90AA1 HSP90AB1 JADE2 COBLL1 SORBS1 EIF3A MAPK9 CDC42 ZHX1	4.64e-06	486	228	14	20936779
Pubmed	Elf5-centered transcription factor hub controls trophoblast stem cell self-renewal and differentiation through stoichiometry-sensitive shifts in target gene networks.	MYO5A DDB1 MKI67 SMARCA5 CHD7 PRPF40A CTNND1	5.17e-06	102	228	7	26584622
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TUBGCP5 ABCA8 SCAF4 ALMS1 DSTYK COBLL1 GPAM HIVEP3 GLCE SBF2 CPEB4 CEP152 EIF3A ZNF512	5.46e-06	493	228	14	15368895
Pubmed	IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells.	NFKB1 PRKCA MAPK9	5.48e-06	6	228	3	19097143
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	TNIK EPS15 NDUFS2 CDKL5 TJP2 HERC2 SIPA1L2 SORBS2 SORBS1 SIPA1L1 MYO1F CTNND1 CDC42	6.10e-06	430	228	13	32581705
Pubmed	Large-Scale Functional Assessment of Genes Involved in Rare Diseases with Intellectual Disabilities Unravels Unique Developmental and Behaviour Profiles in Mouse Models.	PHF8 MECP2 CDKL5 DYNC1H1	8.03e-06	20	228	4	36551904
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	CC2D2A SIPA1L2 HEATR5B TECPR1 ZNFX1 CHD7 SORBS1 TSR1	8.25e-06	153	228	8	10718198
Pubmed	Human transcription factor protein interaction networks.	MYO5A PHF8 DDB1 SCAF4 LENG8 KMT2C SETDB1 MTA3 ALMS1 NFKB1 EIF3L MKI67 HERC2 DYNC1H1 PRRC2B SMARCA5 CHD7 SKI PRPF40A KIAA1671 MIDN CEP152 EIF3A ZNF512 ZHX1	8.78e-06	1429	228	25	35140242
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	USP34 NRIP1 CWF19L2 ZGRF1 SETDB1 ALMS1 SIPA1L2 ZNF714 PRRC2B CHD7 SORBS1 KIAA1671 DROSHA MED25 MAPK9	9.08e-06	588	228	15	38580884
Pubmed	Origin and characteristics of glycogen cells in the developing murine placenta.	MKI67 MMP9 IGF2R	9.55e-06	7	228	3	17039549
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TNIK ALMS1 SIPA1L2 ANKS1A KIAA1671 SIPA1L1 CEP152 EIF3A CTNND1	1.08e-05	209	228	9	36779422
Pubmed	Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.	RPS6KB1 C1orf105 DYNC1H1 PRRC2B HSP90AA1 JADE2 GPAM TEC GLCE CPEB4 CHMP3 PRKCA MAPK9	1.34e-05	463	228	13	27503909
Pubmed	DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC.	MYO1E DDB1 MKI67 NKAP PRPF40A SIPA1L1 CTNND1	1.35e-05	118	228	7	37105989
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	CENPP PARP1 GRK2 DSTYK NFKB1 DYNC1H1 PRRC2B HSP90AA1 HSP90AB1 CDCP1 LARS2	1.37e-05	332	228	11	37433992
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	DDB1 PARP1 GLDC TJP2 HSP90AA1 HSP90AB1 PRPF40A SIPA1L1 EIF3A CTNND1	1.49e-05	274	228	10	34244482
Pubmed	Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33.	HERC2 HSP90AA1 HSP90AB1	1.52e-05	8	228	3	22451720
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TNIK PHF8 SETDB1 SEL1L3 SIPA1L2 DYNC1H1 PRRC2B SORBS2 SORBS1 SIPA1L1 DAAM2 SEZ6L	1.79e-05	407	228	12	12693553
Pubmed	Molecular chaperone Hsp90 regulates REV1-mediated mutagenesis.	PARP1 HSP90AA1 HSP90AB1	2.27e-05	9	228	3	21690293
Pubmed	Interaction network of human early embryonic transcription factors.	KMT2C ALMS1 MKI67 PRRC2B SMARCA5 CALR CHD7 SKI KIAA1671 DNAAF10 ZHX1	2.30e-05	351	228	11	38297188
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	KMT2C ALMS1 MKI67 TECPR1 PTF1A SHROOM2 AKAP12 XIRP2 EIF3A	2.56e-05	233	228	9	37704626
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	MYO5A ZGRF1 PARP1 NGEF HSP90AB1 SMARCA5 COBLL1 TEX15 PRPF40A	2.65e-05	234	228	9	36243803
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	MYO5A SCAF4 PARP1 EIF3L NKAP DYNC1H1 PRRC2B HSP90AA1 HSP90AB1 CPEB2 CPEB3 ZNFX1 PRPF40A FAM133B DROSHA CPEB4 EIF3A	2.71e-05	807	228	17	22681889
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	EPS15 KIZ TUBGCP5 DDB1 EIF3L MKI67 GPC5 NKAP HERC2 DYNC1H1 PRRC2B HSP90AA1 CALR CCDC12 CHAMP1 AKAP12 INF2 TSR1 CHMP3 CEP152 EIF3A	2.74e-05	1155	228	21	20360068
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	NRIP1 ARHGEF11 DDB1 SCAF4 KMT2C DIP2A TJP2 SMARCA5 SORBS1 MIDN XIRP2 ERCC6L2 CTNND1	2.80e-05	497	228	13	36774506
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	NRIP1 MYOM1 CMYA5 ALMS1 MED12L HSP90AA1 HSP90AB1 SORBS1 AKAP12 XIRP2 DROSHA EIF3A MYBPC1	2.80e-05	497	228	13	23414517
Pubmed	Unconventional myosin VI in the heart: Involvement in cardiac dysfunction progressing with age.	RPS6KB1 MKI67 CALR MAPK9	2.80e-05	27	228	4	37169038
Pubmed	The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells.	HSP90AA1 ANKS1A HSP90AB1 FRK PRKCA CTNND1 MAPK9	3.08e-05	134	228	7	24658140
Pubmed	Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.	USP34 PARP1 GRK2 EIF3L NKAP HSP90AA1 HSP90AB1 RBL2 FRK PARVA EIF3A CDC42	3.19e-05	432	228	12	23455922
Pubmed	Deficiency of CPEB2-Confined Choline Acetyltransferase Expression in the Dorsal Motor Nucleus of Vagus Causes Hyperactivated Parasympathetic Signaling-Associated Bronchoconstriction.	CPEB2 CPEB3 CPEB4	3.23e-05	10	228	3	27810937
Pubmed	In silico prediction of physical protein interactions and characterization of interactome orphans.	HSP90AA1 ANKS1A HSP90AB1 FRK PRKCA CTNND1 MAPK9	3.38e-05	136	228	7	25402006
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CWF19L2 CYTH1 DDB1 MECP2 NDUFS2 SCAF4 PARP1 SIPA1L2 DYNC1H1 HSP90AA1 HSP90AB1 NRDE2 SMARCA5 SORBS2 CHD7 CHAMP1 PRPF40A TSR1 DROSHA CPEB4	3.40e-05	1082	228	20	38697112
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 RPS6KB1 KMT2C ZNF780A TJP2 FHIP2B NRDE2 FAM234B CHD7 TEC CDCP1 SHROOM2 AKAP12 IGF2R INF2 TSR1 DNAAF10 SIPA1L1 SBF2 CDC42	3.49e-05	1084	228	20	11544199
Pubmed	Destabilization of TP53 by USP10 is essential for neonatal autophagy and survival.	RPS6KB1 MKI67 HSP90AA1 HSP90AB1	3.76e-05	29	228	4	36198274
Pubmed	Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.	SLC8B1 SEL1L3 MED12L TJP2 HERC2 PRRC2B COL5A1 JADE2 FRK IGF2R SIPA1L1	3.80e-05	371	228	11	15747579
Pubmed	Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).	PARP1 NFKB1	4.28e-05	2	228	2	21646373
Pubmed	Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules.	CALR PRF1	4.28e-05	2	228	2	9671507
Pubmed	MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome.	MECP2 CDKL5	4.28e-05	2	228	2	17089071
Pubmed	A mouse tumor-specific transplantation antigen is a heat shock-related protein.	HSP90AA1 HSP90AB1	4.28e-05	2	228	2	3458168
Pubmed	Rett syndrome: clinical review and genetic update.	MECP2 CDKL5	4.28e-05	2	228	2	15635068
Pubmed	Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy.	PARP1 NFKB1	4.28e-05	2	228	2	17540609
Pubmed	Suppression of matrix metalloproteinase-9 expression in undifferentiated, non-apoptotic keratinocytes is abrogated by the cleavage of poly(ADP-ribose) polymerase-1.	PARP1 MMP9	4.28e-05	2	228	2	21915713
Pubmed	Cell surface heparan sulfate proteoglycans are involved in the binding of Hsp90α and Hsp90β to the cell plasma membrane.	HSP90AA2P HSP90AB1	4.28e-05	2	228	2	26651243
Pubmed	[Ki-67 and matrix metalloproteinase-9 expression in the follicular cyst, keratocystic odontogenic tumor, and ameloblastoma].	MKI67 MMP9	4.28e-05	2	228	2	23805466
Pubmed	HSP90 protects the human T-cell leukemia virus type 1 (HTLV-1) tax oncoprotein from proteasomal degradation to support NF-κB activation and HTLV-1 replication.	NFKB1 HSP90AA1	4.28e-05	2	228	2	24109220
Pubmed	Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.	PTK7 MMP9	4.28e-05	2	228	2	27689325
Pubmed	Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice.	PARP1 NFKB1	4.28e-05	2	228	2	10449410
Pubmed	Proliferation, migration, and resistance to oxidative and thermal stresses of HT1080 cells with knocked out genes encoding Hsp90α and Hsp90β.	HSP90AA1 HSP90AB1	4.28e-05	2	228	2	37406487
Pubmed	Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.	NR1I2 NFKB1	4.28e-05	2	228	2	31490979
Pubmed	The Role of PARP-1 and NF-κB in Bile-Induced DNA Damage and Oncogenic Profile in Hypopharyngeal Cells.	PARP1 NFKB1	4.28e-05	2	228	2	35791892
Pubmed	Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome.	LYST PRF1	4.28e-05	2	228	2	21878672
Pubmed	The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor.	NRIP1 NR1H3	4.28e-05	2	228	2	17684114
Pubmed	[Methyl-CpG-binding protein 2 gene and CDKL5 gene mutation in patients with Rett syndrome: analysis of 177 Chinese pediatric patients].	MECP2 CDKL5	4.28e-05	2	228	2	19552836
Pubmed	Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors.	HSP90AA1 HSP90AB1	4.28e-05	2	228	2	19047110
Pubmed	PMA-induced up-regulation of MMP-9 is regulated by a PKCalpha-NF-kappaB cascade in human lung epithelial cells.	MMP9 PRKCA	4.28e-05	2	228	2	17334233
Pubmed	Matrix metalloproteinase-9 expression in post-hypoxic human brain capillary endothelial cells: H2O2 as a trigger and NF-kappaB as a signal transducer.	NFKB1 MMP9	4.28e-05	2	228	2	12958623
Pubmed	Effect of ulinastatin on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-κB.	NFKB1 MAPK9	4.28e-05	2	228	2	22217202
Pubmed	Heat shock protein HSP86 expression during mouse embryo development, especially in the germ-line.	HSP90AA1 HSP90AB1	4.28e-05	2	228	2	12136260
Pubmed	Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.	PARP1 CDCP1	4.28e-05	2	228	2	22179830
Pubmed	Crosstalk between PARP-1 and NF-kappaB modulates the promotion of skin neoplasia.	PARP1 NFKB1	4.28e-05	2	228	2	15077172
Pubmed	Expression of hsp90 and cyclin D1 in human breast cancer.	HSP90AA1 HSP90AB1	4.28e-05	2	228	2	10376793
Pubmed	Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target.	HSP90AA1 HSP90AB1	4.28e-05	2	228	2	33179566
Pubmed	Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.	NFKB1 PRKCA	4.28e-05	2	228	2	12972622
Pubmed	Regulation of embryonic stem cell pluripotency by heat shock protein 90.	HSP90AA1 HSP90AB1	4.28e-05	2	228	2	22696450
Pubmed	HPV 16 infection up-regulates Piwil2, which affects cell proliferation and invasion in cervical cancer by regulating MMP-9 via the MAPK pathway.	MMP9 PIWIL2	4.28e-05	2	228	2	26775345
Pubmed	Modulation of matrix metalloproteinase-9 activity by hyaluronan is dependent on NF-kappaB activity in lymphoma cell lines with dissimilar invasive behavior.	NFKB1 MMP9	4.28e-05	2	228	2	15474489
Pubmed	Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease.	NR1I2 NFKB1	4.28e-05	2	228	2	31581194
Pubmed	CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome.	MECP2 CDKL5	4.28e-05	2	228	2	15917271
Pubmed	Cdc42 promotes G1 progression through p70 S6 kinase-mediated induction of cyclin E expression.	RPS6KB1 CDC42	4.28e-05	2	228	2	12842876
Pubmed	Skn-1a/Pou2f3 functions as a master regulator to generate Trpm5-expressing chemosensory cells in mice.	TRPM5 POU2F3	4.28e-05	2	228	2	29216297
Pubmed	Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.	AKAP12 PRKCA	4.28e-05	2	228	2	21903576
Pubmed	Effect of poly (ADP-ribose) polymerase-1 inhibition on the proliferation of murine colon carcinoma CT26 cells.	PARP1 NFKB1	4.28e-05	2	228	2	18989759
Pubmed	Inactivation of NF-kappaB p50 leads to insulin sensitization in liver through post-translational inhibition of p70S6K.	RPS6KB1 NFKB1	4.28e-05	2	228	2	19433583
Interaction	VASP interactions	EPS15 DDB1 ALMS1 TJP2 SIPA1L2 EVL COBLL1 SORBS1 PRPF40A KIAA1671 XIRP2 INF2 SIPA1L1 CEP152 CDC42	9.99e-07	294	222	15	int:VASP
Interaction	MST1R interactions	NAAA PTK7 PARP1 MKI67 DYNC1H1 HSP90AA1 SMARCA5 PRPF40A DNAAF10 PRKCA EIF3A ZNF512	2.35e-06	200	222	12	int:MST1R
Interaction	GSK3A interactions	TNIK ARHGEF11 PARP1 ALMS1 SIPA1L2 HSP90AA1 ANKS1A HSP90AB1 SMARCA5 SRBD1 PRPF40A KIAA1671 TSR1 SIPA1L1 PRKCA CEP152 EIF3A CTNND1	4.20e-06	464	222	18	int:GSK3A
Interaction	KCTD13 interactions	MYO1E MYO5A ARHGEF11 DDB1 MECP2 NDUFS2 CDKL5 DIP2A PARP1 GRK2 FGD4 EIF3L NGEF TJP2 UQCRFS1 SIPA1L2 DYNC1H1 PRRC2B HSP90AA1 HSP90AB1 CPEB2 PITPNM2 EVL SORBS2 ZNFX1 SORBS1 SHROOM2 PRPF40A INF2 SIPA1L1 CPEB4 PRKCA EIF3A CTNND1	1.03e-05	1394	222	34	int:KCTD13
Interaction	FRK interactions	GRK2 MKI67 DYNC1H1 HSP90AA1 TEC FRK	1.77e-05	50	222	6	int:FRK
GeneFamily	Heat shock 90kDa proteins	HSP90AA1 HSP90AB1	5.78e-04	5	139	2	586
GeneFamily	Fibronectin type III domain containing	IL12RB2 CRLF1 MYOM1 CMYA5 ROBO2 MYBPC1	1.49e-03	160	139	6	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MYOM1 MDGA2 PTK7 ADAMTSL3 ROBO2 MYBPC1	1.54e-03	161	139	6	593
GeneFamily	Fibronectin type III domain containing\|I-set domain containing\|Myosin binding proteins	MYOM1 MYBPC1	1.59e-03	8	139	2	658
GeneFamily	Myosins, class I	MYO1E MYO1F	1.59e-03	8	139	2	1097
Coexpression	GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP	ADAM19 CRLF1 MYO1E CYTH1 LENG8 MTA3 COBLL1 IDS SKI SIPA1L1 CPEB4	1.31e-06	200	224	11	M9447
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	MYO1E GPC5 HSP90AA1 ANKS1A SORBS2 AKAP12 HIVEP3 SBF2 PRKCA	2.88e-06	137	224	9	M39241
Coexpression	CUI_TCF21_TARGETS_2_DN	MYO1E LYST KMT2C FGD4 DSTYK MED12L HEATR5B HSP90AA1 TECPR1 ANKS1A CPEB2 SORBS1 IDS SHROOM2 FRK INF2 CPEB4 PARVA PRKCA DAAM2 ZHX1	1.54e-05	854	224	21	M1533
Coexpression	GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	ADAM19 MYO1E NFKB1 PITPNM2 EVL FUT10 CHD7 SBF2 CTNND1	2.61e-05	180	224	9	M6878
Coexpression	CUI_TCF21_TARGETS_2_DN	MYO1E LYST KMT2C FGD4 DSTYK MED12L HEATR5B HSP90AA1 TECPR1 ANKS1A CPEB2 SORBS1 IDS SHROOM2 FRK INF2 CPEB4 PARVA PRKCA DAAM2 ZHX1	2.74e-05	888	224	21	MM1018
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	USP34 EPS15 ADAM19 MYO5A CYTH1 TSPYL2 LYST MECP2 KMT2C DIP2A PARP1 GRK2 DSTYK SEL1L3 DYNC1H1 PRRC2B EVL SMARCA5 C6orf62 JADE2 RBL2 ZNFX1 IDS SKI PRPF40A HIVEP3 PRF1 MYO1F CDC42	3.15e-05	1492	224	29	M40023
Coexpression	GSE12366_GC_VS_MEMORY_BCELL_DN	NRIP1 NAAA ZNF780A IQCM TECPR1 ATP13A5 SKI MYO1F CTNND1	5.29e-05	197	224	9	M3173
Coexpression	HALLMARK_MITOTIC_SPINDLE	MYO1E ARHGEF11 TUBGCP5 ALMS1 FGD4 DYNC1H1 SORBS2 SHROOM2 CDC42	5.72e-05	199	224	9	M5893
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	PHACTR2 SLC8B1 CC2D2A COBLL1 SORBS1 TEC CDCP1 SHROOM2 TSR1	5.72e-05	199	224	9	M9179
Coexpression	GSE34515_CD16_POS_MONOCYTE_VS_DC_UP	NRIP1 MYO1E MYO5A ALMS1 HSP90AA1 IDS CHAMP1 HIVEP3 IGF2R	5.94e-05	200	224	9	M8765
ToppCell	LA-06._Ventricular_Cardiomyocyte_II\|LA / Chamber and Cluster_Paper	MYOM1 CMYA5 RYR2 TSGA13 SORBS2 MAGEC3 SORBS1 USP26	2.48e-08	92	228	8	fad2e02ae858e3a9bbe51ad1c689f7e31d11ce0e
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	TNIK ADAM19 MYOM1 CMYA5 RYR2 USP13 SORBS2 SORBS1 XIRP2 CPEB4	3.66e-08	182	228	10	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	TNIK ADAM19 MYOM1 CMYA5 RYR2 USP13 SORBS2 SORBS1 XIRP2 CPEB4	6.37e-08	193	228	10	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	Fetal_29-31_weeks-Immune-dendritic_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADAM19 NAAA MED12L CCL22 MCOLN2 KCTD19 LRRK1 MYO1F RELT	3.44e-07	177	228	9	c5e829bc4594761666d65cace5a9c5d19c16f187
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	CPPED1 NAAA LYST PRAM1 SIPA1L1 SBF2 MYO1F RELT SEZ6L	5.97e-07	189	228	9	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CRLF1 FGD4 GLDC SEL1L3 SORBS2 KCTD19 COBLL1 KIAA1671 GALNT6	6.24e-07	190	228	9	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	ABCA8 RYR2 C1S COL5A1 ADAMTSL3 AKAP12 ADAMTS12 NKD1 ROBO2	8.81e-07	198	228	9	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	ABCA8 RYR2 NALF1 COL5A1 ADAMTSL3 AKAP12 ADAMTS12 NKD1 ROBO2	9.18e-07	199	228	9	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	mLN-Dendritic_cell-cDC2\|Dendritic_cell / Region, Cell class and subclass	PHACTR2 PRAM1 MMP9 EVL MIDN MYO1F PRKCA CTNND1 NUDT15	9.57e-07	200	228	9	e3f7852aaa26a9b3e626d85e40afde799e873045
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA8 RYR2 MCOLN2 COL5A1 ADAMTSL3 AKAP12 ADAMTS12 NKD1 ROBO2	9.57e-07	200	228	9	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CRLF1 MYOM1 ABCA8 C1S COL5A1 SORBS1 NKD1 DAAM2	1.69e-06	159	228	8	cfb4a8c8aac34b1a857956d98382d487abcf5444
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CRLF1 MYOM1 ABCA8 C1S COL5A1 SORBS1 NKD1 DAAM2	1.69e-06	159	228	8	a75ab494959575143cefdaec99e7aee3f318d559
ToppCell	control-Plasmablast\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ADAM19 NPIPB6 BTN1A1 SEL1L3 FAM149A SORBS2 COBLL1 JSRP1	2.23e-06	165	228	8	61063e0ce61bc92d5d1093be8279af03f650720b
ToppCell	Adult-Immune-dendritic_cell\|Adult / Lineage, Cell type, age group and donor	ADAM19 NAAA NPIPB9 MED12L CCL22 MCOLN2 LRRK1 TEX15	2.23e-06	165	228	8	073f52698dac1fe4edd7410865f81b30e1c7196a
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCSK1 ADAM19 DDB1 CHRNA6 XIRP2 GLCE RASGEF1C PRKCA	2.33e-06	166	228	8	6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	MYOM1 MYO5A CMYA5 RYR2 SORBS2 XIRP2 CPEB4 TEC	2.78e-06	170	228	8	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAM19 MYOM1 CMYA5 RYR2 USP13 SORBS2 SORBS1 XIRP2	3.60e-06	176	228	8	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK1 GPR179 SEL1L3 MED12L PCYT1B CDCP1 CEP152 SEZ6L	3.76e-06	177	228	8	8abdf1d970b2f15e17e185f3e612dd5065c88757
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	POU2F3 FAM234B NR1H3 LARS2 CHAMP1 GLCE TEC	4.63e-06	129	228	7	2f30b4897343586c9b49a1d2bec3007ec737085c
ToppCell	Control-B_activate-7\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TCP10L MED12L FAM47E ABCC2 CCL22 IMPG2 SORBS1	4.87e-06	130	228	7	d3343c19d61928f18e7d707eda5dec6e0fd2a9a2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK ADAM19 MYO1E RYR2 SORBS2 SORBS1 CDCP1 AKAP12	5.00e-06	184	228	8	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A KIZ NALF1 GLDC COBLL1 ADAMTSL3 PRKCA ROBO2	5.20e-06	185	228	8	d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADAM19 NFKB1 MMP9 CCL22 MCOLN2 CDCP1 AKAP12 SIPA1L1	5.41e-06	186	228	8	0dce13e15c3bf32610bf2dad31253b52a39cff87
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	LYST GLDC NGEF ABCC2 SORBS2 COBLL1 GPAM SBF2	5.63e-06	187	228	8	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ADAM19 MYOM1 CMYA5 RYR2 SORBS2 SORBS1 CPEB4 ROBO2	5.86e-06	188	228	8	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MYOM1 CMYA5 RYR2 USP13 SORBS2 SORBS1 XIRP2 CPEB4	6.09e-06	189	228	8	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil\|COVID_vent / Disease condition, Lineage, Cell class and subclass	NRIP1 CLGN PTK7 MED12L PCYT1B COL5A1 CDCP1 AKAP12	6.09e-06	189	228	8	2157a2d40613f7d5ce2e7dbd266df441e449cdaf
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	ABCA8 RYR2 COL5A1 ADAMTSL3 AKAP12 ADAMTS12 NKD1 ROBO2	6.33e-06	190	228	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	10x5'-Lung-Myeloid_Monocytic-Nonclassical_monocytes\|Lung / Manually curated celltypes from each tissue	CPPED1 NAAA LYST PRAM1 PROZ GRK2 UMODL1 SEZ6L	6.58e-06	191	228	8	a862a571625ab7238589ff201e5954f602c3bd7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA8 C1S COL5A1 SORBS1 ADAMTSL3 ADAMTS12 NKD1 DAAM2	6.83e-06	192	228	8	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA8 C1S COL5A1 SORBS1 ADAMTSL3 ADAMTS12 NKD1 DAAM2	6.83e-06	192	228	8	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	KIZ MTA3 GLDC ABCC2 SORBS2 COBLL1 GPAM NKD1	7.10e-06	193	228	8	503a979328c68b096680b71359a26f02fafdff35
ToppCell	nucseq-Immune-Immune_Myeloid-pMON-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CPPED1 NAAA LYST PRAM1 GRK2 SIPA1L1 SBF2 MYO1F	7.37e-06	194	228	8	e237384b02be460d44eeada3026a5691c66f6fc1
ToppCell	nucseq-Immune-Immune_Myeloid-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CPPED1 NAAA LYST PRAM1 GRK2 SIPA1L1 SBF2 MYO1F	7.37e-06	194	228	8	0bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell	Control-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	ABCA8 RYR2 C1S COL5A1 AKAP12 ADAMTS12 NKD1 ROBO2	7.37e-06	194	228	8	3c2266772c5b56e8e02a461e5193e29588028ee9
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	MYOM1 CMYA5 RYR2 USP13 SORBS2 SORBS1 XIRP2 CPEB4	7.65e-06	195	228	8	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	TNIK MYOM1 CMYA5 RYR2 USP13 SORBS2 SORBS1 CPEB4	7.65e-06	195	228	8	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	distal-Hematologic-Nonclassical_Monocyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CPPED1 NAAA LYST PRAM1 GRK2 MYO1F RELT SEZ6L	7.65e-06	195	228	8	6f417bb464b8ae6a50bbab5db5a6d5760c02122f
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK1 TRPM5 NALF1 PRRC2B IDS PRKCA ROBO2 SEZ6L	7.65e-06	195	228	8	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA8 RYR2 COL5A1 ADAMTSL3 AKAP12 ADAMTS12 NKD1 ROBO2	7.94e-06	196	228	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	distal-3-Hematologic-Nonclassical_Monocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CPPED1 NAAA LYST PRAM1 GRK2 MYO1F RELT SEZ6L	7.94e-06	196	228	8	c1f3334bc09f5d0cfb9d998a3a64f0700426a357
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA8 RYR2 C1S COL5A1 ADAMTSL3 ADAMTS12 NKD1 ROBO2	7.94e-06	196	228	8	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	COVID-19-Heart-Mito_CM\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYOM1 CMYA5 RYR2 UQCRFS1 SORBS2 JSRP1 XIRP2 MYBPC1	8.24e-06	197	228	8	44e49943d62bfe622b40ad0460093d31540544df
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TNIK TSPYL2 SEL1L3 HSP90AB1 EVL JADE2 RBL2 PRF1	8.24e-06	197	228	8	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	lymphoid-T_cell-unlabelled(multiplets)\|lymphoid / Lineage, cell class and subclass	ADAM19 TSPYL2 MMP9 HSP90AA1 IDS SKI MIDN MYO1F	8.24e-06	197	228	8	a224c0a010489ad043bd2ad1385eef33c3b6b792
ToppCell	distal-Hematologic-Nonclassical_Monocyte-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CPPED1 NAAA LYST PRAM1 GRK2 MYO1F RELT SEZ6L	8.24e-06	197	228	8	e817c1a8549e403e723b1b6c73cdb04f1179909d
ToppCell	Control-gd_T\|Control / Disease condition and Cell class	IL12RB2 LENG8 GRK2 CALR CCDC12 FAM133B MIDN MYO1F	8.24e-06	197	228	8	000b3269c152d80527b5ad9412dd4e71b73ef1ca
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA8 RYR2 NALF1 COL5A1 ADAMTSL3 AKAP12 ADAMTS12 ROBO2	8.55e-06	198	228	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA8 RYR2 C1S COL5A1 ADAMTSL3 ADAMTS12 NKD1 ROBO2	8.55e-06	198	228	8	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK CWF19L2 TSPYL2 SEL1L3 EVL COBLL1 CHD7 PRF1	8.55e-06	198	228	8	a3bd099ef0e606c2da690a6fcf6f79e9360c9c9f
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA8 RYR2 PTK7 C1S MCOLN2 COL5A1 EVL ADAMTS12	8.87e-06	199	228	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABCA8 PTK7 C1S MCOLN2 COL5A1 EVL AKAP12 ADAMTS12	8.87e-06	199	228	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TSPYL2 RYR2 PTK7 NFKB1 C1S MCOLN2 EVL HIVEP3	8.87e-06	199	228	8	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|megakaryocytic / Lineage and Cell class	NRIP1 PARP1 EIF3L MED12L HSP90AB1 PRPF40A FAM133B EIF3A	8.87e-06	199	228	8	99a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA8 RYR2 COL5A1 ADAMTSL3 AKAP12 ADAMTS12 NKD1 ROBO2	9.20e-06	200	228	8	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Hematolymphoid-Microglia-TYROBP--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	NRIP1 FGD4 MED12L EVL LRRK1 HIVEP3 MYO1F RASGEF1C	9.20e-06	200	228	8	dc344b3ec51d506952e38f0b3a7795d65f9dd4eb
ToppCell	Hematolymphoid-Microglia\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	NRIP1 FGD4 MED12L EVL LRRK1 HIVEP3 MYO1F RASGEF1C	9.20e-06	200	228	8	21bcca3b670fe9bac034aef2275d3de4a9a73e2b
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA8 RYR2 COL5A1 ADAMTSL3 AKAP12 ADAMTS12 NKD1 ROBO2	9.20e-06	200	228	8	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA8 RYR2 PTK7 C1S MCOLN2 COL5A1 EVL AKAP12	9.20e-06	200	228	8	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Hematolymphoid-Microglia-TYROBP\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	NRIP1 FGD4 MED12L EVL LRRK1 HIVEP3 MYO1F RASGEF1C	9.20e-06	200	228	8	33036d21c1c82109284473a515c4f890b33fdd5c
ToppCell	Hematolymphoid-Microglia-TYROBP----L1-3\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	NRIP1 FGD4 MED12L EVL LRRK1 HIVEP3 MYO1F RASGEF1C	9.20e-06	200	228	8	a20dce14f94777687aad57d6fbe3258ad376f63f
ToppCell	Hematolymphoid-Microglia-TYROBP-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	NRIP1 FGD4 MED12L EVL LRRK1 HIVEP3 MYO1F RASGEF1C	9.20e-06	200	228	8	3bba5219453322198e8fdb0921d5f8c403598751
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA8 RYR2 COL5A1 ADAMTSL3 AKAP12 ADAMTS12 NKD1 ROBO2	9.20e-06	200	228	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA8 RYR2 COL5A1 ADAMTSL3 AKAP12 ADAMTS12 NKD1 ROBO2	9.20e-06	200	228	8	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Hematolymphoid-Microglia-TYROBP---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	NRIP1 FGD4 MED12L EVL LRRK1 HIVEP3 MYO1F RASGEF1C	9.20e-06	200	228	8	a8646d0fca99f10827c2d2a12e584660ef7155f1
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	ABCA8 PTK7 MCOLN2 COL5A1 EVL TEX15 AKAP12 ADAMTS12	9.20e-06	200	228	8	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A MKI67 CCL22 IQCM PTF1A LARS2 MYO1F	1.54e-05	155	228	7	0e24e767a3895d31d34cabeaca0354aadae34e44
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A MKI67 CCL22 IQCM PTF1A LARS2 MYO1F	1.54e-05	155	228	7	f3489a548a2c0cc2d9117ff85865c6089ea0835d
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM19 LYST PRAM1 FGD4 MED12L MMP9 MYO1F	1.97e-05	161	228	7	e227f7b711475624cf80e77f235b1783d88d57b4
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM19 LYST PRAM1 FGD4 MED12L MMP9 MYO1F	1.97e-05	161	228	7	8280a029026c272cae9649b27575831b0dd4e242
ToppCell	Children_(3_yrs)-Immune-dendritic_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAM19 NAAA MED12L CCL22 MCOLN2 LRRK1 MYBPC1	1.97e-05	161	228	7	cd41abb7ae659d3d314281783a0aaad562b26037
ToppCell	Dendritic_Cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	ADAM19 NAAA CCL22 IMPG2 MCOLN2 CHRNA6 MYO1F	2.13e-05	163	228	7	5fff3932c1c259010e3add7a3b2301df2fa37df1
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-9\|TCGA-Brain / Sample_Type by Project: Shred V9	TNIK TJP2 GPAM SORBS1 ADAMTSL3 KIAA1671 DAAM2	2.49e-05	167	228	7	013971700e80b71e4b8c79b8fff0d8beeac295c3
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	MYO1E MED12L TJP2 CC2D2A MCOLN2 KCTD19 SORBS1	2.59e-05	168	228	7	968405ea56f7d001ef83ff9274610923c3b2d55d
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL12RB2 EVL RBL2 IDS PRF1 PROX2 ERMARD	2.69e-05	169	228	7	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CYP24A1 C1S POU2F3 ATP13A5 FRK	2.76e-05	69	228	5	cdd42abdd072aa438830d837ee857529269a81e0
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CYP24A1 C1S POU2F3 ATP13A5 FRK	2.76e-05	69	228	5	a157b1582401cebd222343d94086dbea876140c2
ToppCell	Control-B_activate-7\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TCP10L MED12L FAM47E CCL22 IMPG2 SORBS1	2.82e-05	115	228	6	cc2f8fb0cbb72b241b65a69195aac0507bddf2e2
ToppCell	Healthy_donor-Plasmablast\|World / disease group, cell group and cell class (v2)	NR1I2 GLDC NPIPB6 BTN1A1 COBLL1 JSRP1 FRK	3.36e-05	175	228	7	5293e00fda63a291aa393bdf82ebd4b80265049f
ToppCell	pdx-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	NGEF ABCC2 SORBS2 COBLL1 GPAM CPEB4 ROBO2	3.49e-05	176	228	7	1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA8 RYR2 NALF1 C1S COL5A1 ADAMTSL3 NKD1	3.61e-05	177	228	7	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPAM SORBS1 TEX15 SHROOM2 RASGEF1C DAAM2 TEC	3.61e-05	177	228	7	59cf56c385c324f0844f20003d2b5049a2791e45
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA8 RYR2 NALF1 C1S COL5A1 ADAMTSL3 NKD1	3.61e-05	177	228	7	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADAM19 GLDC NPIPB6 BTN1A1 SEL1L3 COBLL1 JSRP1	3.75e-05	178	228	7	6765c6970b1f2b719a20d2afd7471e1c262f3fc4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADAM19 GLDC NPIPB6 BTN1A1 SEL1L3 COBLL1 JSRP1	3.75e-05	178	228	7	693f1135d9c5545945e80c7ba3d098afc0ccac29
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRLF1 GLDC NGEF C1S CPEB2 GPAM PRKCA	3.88e-05	179	228	7	e880c507f11ce75d104593a4ca29f0295f8125e8
ToppCell	-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	TNMD ABCA8 C1S COL5A1 ADAMTSL3 ADAMTS12 NKD1	3.88e-05	179	228	7	10fadbaa1b6d21cbf9f354d717cc4c225619f4fd
ToppCell	FF-Differ-KC\|World / shred by cell class for mouse tongue	TNIK GLDC TSGA13 SORBS1 NKD1 ROBO2 GALNT6	3.88e-05	179	228	7	1526a130565a97c291a25a7a988089bffc1515c1
ToppCell	RV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	NPIPB7 MYOM1 CMYA5 RYR2 SORBS2 SORBS1	3.93e-05	122	228	6	1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PHACTR2 MYO1E NALF1 GLDC COBLL1 ADAMTSL3 PRKCA	4.02e-05	180	228	7	788d5fbf688365b5d92d3aa19b9f8e9448f8be5a
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAM19 MYOM1 CMYA5 RYR2 SORBS2 SORBS1 XIRP2	4.17e-05	181	228	7	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA8 SORBS1 ADAMTSL3 AKAP12 ADAMTS12 NKD1 DAAM2	4.31e-05	182	228	7	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR1I2 PROZ GLDC C1S ABCC2 DMGDH GPAM	4.31e-05	182	228	7	77ab860e2add49dad0c1ffbfc64278ad499dfbd5
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR1I2 PROZ GLDC C1S ABCC2 DMGDH GPAM	4.31e-05	182	228	7	4921c7d5687cc79f896b39753bb621d7e3d2972f
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR1I2 PROZ GLDC C1S ABCC2 DMGDH GPAM	4.31e-05	182	228	7	770ce9f3f4538d0181a0181543841bc964c68274
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E TRPM5 NALF1 GLDC COBLL1 ADAMTSL3 PRKCA	4.31e-05	182	228	7	f96095b81188b52db8fcfca4837129cfcd9bd7b7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA8 SORBS1 ADAMTSL3 AKAP12 ADAMTS12 NKD1 DAAM2	4.31e-05	182	228	7	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 MDGA2 COL5A1 SORBS1 AKAP12 NKD1 DAAM2	4.47e-05	183	228	7	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	COVID-19-APC-like\|COVID-19 / group, cell type (main and fine annotations)	ADAM19 NAAA MED12L CCL22 MCOLN2 LRRK1 RELT	4.47e-05	183	228	7	b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9
ToppCell	COVID-19-APC-like-Dendritic_cells\|COVID-19 / group, cell type (main and fine annotations)	ADAM19 NAAA MED12L CCL22 MCOLN2 LRRK1 RELT	4.47e-05	183	228	7	703364836b42aa6ac6c68b42b700ac23c4a1afc7
Drug	AC1L1DW2	CRLF1 RYR2 PARP1 GRK2 HSP90AA1 HSP90AA2P HSP90AB1 CAPN6 CDCP1 PRKCA CTNND1	2.59e-06	186	225	11	CID000002532
Drug	wartmannin	MYO1E MYO5A CYTH1 RPS6KB1 PARP1 GRK2 FGD4 PI4KB NFKB1 C2 MMP9 HSP90AA1 HSP90AA2P RBL2 PIWIL2 TEC IGF2R SBF2 CHMP3 PRKCA MAPK9 CDC42 ZHX1	6.12e-06	811	225	23	CID000005691
Drug	SC-10	HSP90AA1 HSP90AA2P PCYT1B HSP90AB1 PRKCA	7.36e-06	28	225	5	CID000005175
Drug	2,3-dimethylindoline	C2 RBL2 DROSHA	9.39e-06	5	225	3	CID000030944
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; HL60; HT_HG-U133A	ELOA2 NAAA MYOM1 CYTH1 SEL1L3 CCL22 CDCP1 SIPA1L1 CTNND1 SEZ6L	1.06e-05	176	225	10	2926_UP
Drug	AC1L9PMA	NFKB1 HSP90AA1 HSP90AA2P HSP90AB1	1.16e-05	15	225	4	CID000451405
Drug	fexofenadine	NR1I2 NFKB1 ABCC2 MMP9 CCL22	1.46e-05	32	225	5	ctd:C093230
Drug	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid	RPS6KB1 PARP1 MMP9 HSP90AA1 HSP90AB1	1.46e-05	32	225	5	ctd:C025603
Drug	evodiamine	PARP1 NFKB1 MMP9 PRKCA MAPK9	1.99e-05	34	225	5	ctd:C049639
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	CPPED1 MYO1E SETDB1 SGSM3 FHIP2B CALR RBL2 COBLL1 CEP152 EDRF1	2.25e-05	192	225	10	6990_DN
Drug	Hemicholinium bromide [312-45-8]; Up 200; 7uM; PC3; HT_HG-U133A	PHF8 DSTYK SGSM3 MMP9 FAM234B COBLL1 PARVA CEP152 CDC42 SEZ6L	2.46e-05	194	225	10	6739_UP
Drug	17-DMAG; Up 200; 0.1uM; PC3; HT_HG-U133A	CYTH1 POU2F3 HSP90AB1 FAM234B YJU2 KLHL36 PCIF1 MED25 PRKCA EDRF1	2.46e-05	194	225	10	1213_UP
Drug	Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A	USP34 CYTH1 GRK2 NALF1 SGSM3 ABCC2 FAM149A CHRNA6 AKAP12 MYO1F	2.68e-05	196	225	10	7225_UP
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A	CPPED1 ELOA2 NAAA LYST RYR2 DSTYK COL5A1 COBLL1 SIPA1L1 EDRF1	2.80e-05	197	225	10	5387_DN
Drug	liu	MYO5A CYP24A1 GRK2 SGSM3 HSP90AA1 HSP90AA2P CALR RBL2 ADAMTS12 IGF2R GLCE MAPK9	2.88e-05	285	225	12	CID015991562
Drug	pentafluorophenol	BTN1A1 DNAAF10 PRF1	3.24e-05	7	225	3	CID000013041
Drug	NSC330499	HSP90AA1 HSP90AA2P HSP90AB1	3.24e-05	7	225	3	CID000433447
Drug	GW 501516	KIZ CYP24A1 PARP1 NFKB1 MMP9 NR1H3	3.70e-05	63	225	6	ctd:C425931
Drug	dimethyl pimelimidate	MYO5A HSP90AA1 HSP90AA2P HSP90AB1	3.97e-05	20	225	4	CID000065403
Drug	CGP7040	LYST HSP90AA1 HSP90AA2P MAPK9	3.97e-05	20	225	4	CID006436259
Drug	phenyldichloroarsine	HSP90AA1 HSP90AA2P HSP90AB1	5.14e-05	8	225	3	CID000012762
Drug	5,8-quinolinedione	HSP90AA1 HSP90AA2P HSP90AB1	7.66e-05	9	225	3	CID000388306
Drug	3-amino-5-chlorobenzoic acid	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID010986726
Drug	monocillin III	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID006478910
Drug	pochonin A	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID006478909
Drug	PU-H71	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID009549213
Drug	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	HSP90AA1 HSP90AB1	9.72e-05	2	225	2	DB02754
Drug	1uyc	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID000448969
Drug	PU-9	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID000448971
Drug	P u 0	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID000448974
Drug	2qf6	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID013373715
Drug	Geldanamycin	HSP90AA1 HSP90AB1	9.72e-05	2	225	2	DB02424
Drug	CHEBI:42139	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID011562562
Drug	2qfo	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID000600769
Drug	3eko	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID011160307
Drug	8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE	HSP90AA1 HSP90AB1	9.72e-05	2	225	2	DB07877
Drug	1uyi	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID005289232
Drug	4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL	HSP90AA1 HSP90AB1	9.72e-05	2	225	2	DB07594
Drug	NSC683666	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID005469153
Drug	H 64	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID006914564
Drug	SureCN4151355	HSP90AA1 HSP90AA2P	9.72e-05	2	225	2	CID015942101
Drug	1alpha,20-dihydroxyvitamin D3	CYP11A1 CYP24A1	9.72e-05	2	225	2	ctd:C539020
Drug	Go 6976	CYP11A1 PARP1 ABCC2 MMP9 PRKCA CTNND1	9.94e-05	75	225	6	ctd:C081021
Drug	maysin	LYST BTN1A1 C2	1.09e-04	10	225	3	CID000194340
Drug	AC1L44ZM	NFKB1 HSP90AA1 HSP90AA2P	1.09e-04	10	225	3	CID000200744
Drug	tautomycin	RPS6KB1 PARP1 CALR	1.09e-04	10	225	3	ctd:C053079
Drug	Calpain inhibitor I	CRLF1 PARP1 NFKB1 HSP90AA1 HSP90AA2P HSP90AB1 CAPN6 NR1H3 PRKCA CTNND1 MAPK9	1.15e-04	280	225	11	CID000004332
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A	TNIK USP34 DIP2A ALMS1 DSTYK C1orf105 KLHL36 PRF1 CEP152	1.30e-04	192	225	9	3729_DN
Drug	Bile Acids and Salts	NR1I2 NFKB1 ABCC2 HSP90AB1 NR1H3 PRKCA	1.33e-04	79	225	6	ctd:D001647
Drug	Ceforanide [60925-61-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A	LYST SCAF4 DSTYK SGSM3 COBLL1 TEX15 TSR1 CEP152 EDRF1	1.35e-04	193	225	9	5351_UP
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	SLC8B1 GRK2 PI4KB MMP9 FAM234B CALR COBLL1 KLHL36 PARVA	1.40e-04	194	225	9	2863_DN
Drug	Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A	ELOA2 CRLF1 TSPYL2 COL5A1 JADE2 COBLL1 HIVEP3 PRF1 MYO1F	1.40e-04	194	225	9	4848_DN
Drug	17-AAG; Up 200; 1uM; ssMCF7; HG-U133A	PHF8 HSP90AA1 HSP90AB1 CALR YJU2 PRF1 MYO1F PARVA PCIF1	1.46e-04	195	225	9	521_UP
Drug	Lactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	IL12RB2 MYO1E TUBGCP5 SCAF4 POU2F3 CHRNA6 SRBD1 SKI SIPA1L1	1.46e-04	195	225	9	3246_UP
Drug	Pu-3	HSP90AA1 HSP90AA2P HSP90AB1	1.48e-04	11	225	3	CID000448965
Drug	Gt12	IGF2R MAPK9 CDC42	1.48e-04	11	225	3	CID000164934
Drug	liquoid	NAAA C1S C2	1.48e-04	11	225	3	CID006434512
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A	CYTH1 RYR2 C1orf105 MMP9 CHRNA6 LRRK1 PRF1 MED25 DAAM2	1.52e-04	196	225	9	3742_DN
Drug	Sulpiride [15676-16-1]; Down 200; 11.8uM; HL60; HG-U133A	USP34 EPS15 ARHGEF11 MKI67 FHIP2B FAM234B SMARCA5 LRRK1 TSR1	1.52e-04	196	225	9	1967_DN
Drug	(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; HL60; HT_HG-U133A	MECP2 RYR2 GRK2 PI4KB SGSM3 IDS LARS2 PCIF1 EDRF1	1.52e-04	196	225	9	2496_DN
Drug	Stachydrine hydrochloride; Up 200; 22.2uM; MCF7; HT_HG-U133A	CLGN NAAA RYR2 GRK2 FAM149A SORBS1 TEC PARVA SEZ6L	1.57e-04	197	225	9	6805_UP
Drug	Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A	USP34 NAAA MECP2 GRK2 DSTYK C1orf105 COL5A1 NR1H3 PRKCA	1.57e-04	197	225	9	6261_UP
Drug	Lovastatin [75330-75-5]; Down 200; 9.8uM; PC3; HT_HG-U133A	CPPED1 NAAA ABCC2 COBLL1 HIVEP3 YJU2 MYO1F PARVA MED25	1.57e-04	197	225	9	6633_DN
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; PC3; HT_HG-U133A	CPPED1 MECP2 DSTYK COL5A1 SORBS2 SKI PARVA MED25 PRKCA	1.57e-04	197	225	9	4684_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	PHF8 TUBGCP5 MECP2 SGSM3 MMP9 RBL2 COBLL1 PCIF1 CEP152	1.57e-04	197	225	9	6974_DN
Drug	Protein Kinase Inhibitors	CYP24A1 PARP1 NFKB1 ABCC2 MAPK9	1.61e-04	52	225	5	ctd:D047428
Drug	Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; HL60; HT_HG-U133A	TNIK ELOA2 MYO1E SGSM3 ABCC2 FHIP2B HIVEP3 INF2 CTNND1	1.64e-04	198	225	9	3088_DN
Drug	Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; PC3; HT_HG-U133A	CPPED1 ELOA2 SGSM3 ABCC2 CCL22 FAM234B FRK PRF1 PARVA	1.64e-04	198	225	9	4609_UP
Drug	Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; PC3; HT_HG-U133A	USP34 ARHGEF11 PTK7 SCAF4 ALDH3A1 PRRC2B FHIP2B NR1H3 KLHL36	1.64e-04	198	225	9	7399_DN
Drug	Carisoprodol [78-44-4]; Up 200; 15.4uM; HL60; HT_HG-U133A	USP34 CLGN PI4KB SGSM3 CDCP1 SIPA1L1 PRKCA CEP152 CTNND1	1.70e-04	199	225	9	1314_UP
Drug	Spiperone [749-02-0]; Down 200; 10.2uM; HL60; HG-U133A	SCAF4 DIP2A TJP2 CHRNA6 RBL2 IDS TSR1 EIF3A MAPK9	1.70e-04	199	225	9	1559_DN
Drug	C070379	RYR2 PARP1 GRK2 NFKB1 CALR DNAAF10 PRKCA MAPK9 CDC42	1.70e-04	199	225	9	CID003034747
Drug	IN1025	RPS6KB1 NR1I2 GPAM AKAP12 IGF2R GLCE	1.74e-04	83	225	6	CID000415541
Drug	8-MOP	CYP11A1 CYP24A1 TSPYL2 LYST DDB1 NR1I2 POU2F3	1.75e-04	118	225	7	CID000004114
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	USP34 LYST SLC8B1 SGSM3 SMARCA5 JADE2 COBLL1 SKI CEP152	1.76e-04	200	225	9	4701_DN
Drug	Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; HL60; HT_HG-U133A	ARHGEF11 SGSM3 FHIP2B CHRNA6 TEC IDS CDCP1 LARS2 INF2	1.76e-04	200	225	9	1281_UP
Drug	butirosin A from Bacillus vitellinus; Down 200; 10uM; PC3; HG-U133A	NRIP1 MECP2 PRRC2B SHROOM2 HIVEP3 PARVA DAAM2 EDRF1 SEZ6L	1.76e-04	200	225	9	666_DN
Disease	lung cancer (is_marker_for)	CYP24A1 NFKB1 MKI67 CCL22 CALR	1.01e-05	39	219	5	DOID:1324 (is_marker_for)
Disease	cutaneous melanoma	PARP1 DSTYK HERC2 POU2F3 FHIP2B AKAP12 ADAMTS12	3.48e-05	121	219	7	EFO_0000389
Disease	bacterial meningitis (is_implicated_in)	PARP1 MMP9	5.48e-05	2	219	2	DOID:9470 (is_implicated_in)
Disease	Rett syndrome (is_implicated_in)	MECP2 CDKL5	5.48e-05	2	219	2	DOID:1206 (is_implicated_in)
Disease	Colorectal Carcinoma	ELOA2 ADAM19 RPS6KB1 ABCA8 CDKL5 KMT2C PARP1 MKI67 ABCC2 EVL CALR CAPN6 ADAMTSL3 AKAP12 HIVEP3 EDRF1	7.81e-05	702	219	16	C0009402
Disease	triglycerides to total lipids in very small VLDL percentage	PRAM1 DMGDH COBLL1 GPAM PCIF1	1.64e-04	69	219	5	EFO_0022341
Disease	multiple sclerosis (is_implicated_in)	PHACTR2 NDUFS2 MMP9 HSP90AB1 PRF1	2.14e-04	73	219	5	DOID:2377 (is_implicated_in)
Disease	Charcot-Marie-Tooth disease	FGD4 DYNC1H1 INF2 SBF2	2.65e-04	42	219	4	cv:C0007959
Disease	smoking behavior, BMI-adjusted waist circumference	ANKS1A KCTD19 COBLL1 ADAMTSL3 CPEB4 MYO1F	3.08e-04	122	219	6	EFO_0004318, EFO_0007789
Disease	Vesico-Ureteral Reflux	DSTYK ROBO2	3.26e-04	4	219	2	C0042580
Disease	Angelman Syndrome	MECP2 CDKL5	3.26e-04	4	219	2	C0162635
Disease	tyrosine-protein kinase TEC measurement	TEC TEC	3.26e-04	4	219	2	EFO_0020830
Disease	systemic scleroderma	IL12RB2 PXK NFKB1 MMP9 CHD7	4.36e-04	85	219	5	EFO_0000717
Disease	Alzheimer's disease biomarker measurement	GLDC AKAP12 RASGEF1C MAPK9	4.45e-04	48	219	4	EFO_0006514
Disease	hyperglycemia (biomarker_via_orthology)	PCSK1 CYP11A1 MMP9	4.86e-04	21	219	3	DOID:4195 (biomarker_via_orthology)
Disease	platelet-activating factor measurement	NALF1 IQCM	5.40e-04	5	219	2	EFO_0801075
Disease	Rett Syndrome	MECP2 CDKL5	5.40e-04	5	219	2	C0035372
Disease	Arterial Fatty Streak	PARP1 NR1I2	5.40e-04	5	219	2	C0015697
Disease	Lupus Erythematosus, Discoid	TSPYL2 C2	5.40e-04	5	219	2	C0024138
Disease	Atheroma	PARP1 NR1I2	5.40e-04	5	219	2	C0264956
Disease	Plaque, Atherosclerotic	PARP1 NR1I2	5.40e-04	5	219	2	C2936350
Disease	Fibroatheroma	PARP1 NR1I2	5.40e-04	5	219	2	C2936351
Disease	testosterone measurement	PCSK1 CPPED1 MYO5A CYP24A1 ABCA8 NALF1 NFKB1 C2 FAM47E NRDE2 JADE2 COBLL1 GPAM CHD7 CCDC12 CHAMP1 CLYBL SBF2 CPEB4 PRKCA DAAM2	5.69e-04	1275	219	21	EFO_0004908
Disease	nevus count, cutaneous melanoma	PARP1 HERC2 POU2F3 FHIP2B AKAP12	5.96e-04	91	219	5	EFO_0000389, EFO_0004632
Disease	Neurodevelopmental Disorders	MECP2 PTK7 CDKL5 KMT2C HIVEP3	6.58e-04	93	219	5	C1535926
Disease	stomach cancer (is_marker_for)	PARP1 GLDC NFKB1 MKI67 MMP9 CALR	6.91e-04	142	219	6	DOID:10534 (is_marker_for)
Disease	triglycerides to total lipids in medium HDL percentage	ABCA8 COBLL1 NR1H3 PCIF1	8.02e-04	56	219	4	EFO_0022333
Disease	pappalysin-1 measurement	USP34 CHD7	8.07e-04	6	219	2	EFO_0802845
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	ABCA8 FAM47E PITPNM2 DMGDH COBLL1 GPAM IGF2R PCIF1	8.42e-04	264	219	8	EFO_0008317, EFO_0020944
Disease	forced expiratory volume	ADAM19 RYR2 CENPP GPC5 PRRC2B HSP90AA1 ANKS1A DMGDH SKI LARS2 ADAMTSL3 DROSHA ERCC6L2 RASGEF1C MYBPC1	8.73e-04	789	219	15	EFO_0004314
Disease	Seizures, Focal	CYP11A1 MECP2 CDKL5 ABCC2 DYNC1H1	1.09e-03	104	219	5	C0751495
Disease	T-cell immunoglobulin and mucin domain 1 measurement	ADAM19 ABCA8	1.12e-03	7	219	2	EFO_0010812
Disease	abnormal vaginal discharge smell	CYP24A1 SORBS2	1.12e-03	7	219	2	EFO_0009408
Disease	Aortic Aneurysm	MMP9 SKI	1.12e-03	7	219	2	C0003486
Disease	type 2 diabetes mellitus (implicated_via_orthology)	PCSK1 RPS6KB1 PARP1 ALMS1 MAPK9	1.14e-03	105	219	5	DOID:9352 (implicated_via_orthology)
Disease	primary biliary cholangitis (biomarker_via_orthology)	RPS6KB1 ABCC2 MMP9	1.15e-03	28	219	3	DOID:12236 (biomarker_via_orthology)
Disease	triglycerides to total lipids in IDL percentage	DMGDH COBLL1 GPAM PCIF1	1.25e-03	63	219	4	EFO_0022329
Disease	keratoconus	ALDH3A1 COL5A1 EIF3A GALNT6	1.48e-03	66	219	4	MONDO_0015486
Disease	X-11787 measurement	ALMS1 CLYBL	1.49e-03	8	219	2	EFO_0021258
Disease	memory impairment	FUT10 PRPF40A	1.49e-03	8	219	2	EFO_0001072
Disease	cholesterol to total lipids in very small VLDL percentage	DMGDH COBLL1 GPAM PCIF1	1.57e-03	67	219	4	EFO_0022245
Disease	phospholipids:total lipids ratio	ABCA8 PRAM1 DMGDH COBLL1 GPAM IGF2R PCIF1	1.60e-03	227	219	7	EFO_0020946
Disease	sexual dimorphism measurement	ABCA8 PRAM1 SETDB1 NPIPB6 BTN1A1 C1orf105 MMP9 TBC1D21 ANKS1A PITPNM2 KCTD19 COBLL1 GPAM ADAMTSL3 FAM133B FRK MYO1F PCIF1	1.61e-03	1106	219	18	EFO_0021796
Disease	C-reactive protein measurement	PCSK1 USP34 CWF19L2 ADAM19 RPS6KB1 PTK7 SCAF4 NR1I2 DSTYK NFKB1 ANKS1A DMGDH COBLL1 CHD7 CCDC12 FRK MROH6 PCIF1 ZNF512	1.73e-03	1206	219	19	EFO_0004458
Disease	rheumatoid arthritis (is_marker_for)	GRK2 MMP9 CCL22 HSP90AA1	1.75e-03	69	219	4	DOID:7148 (is_marker_for)
Disease	Liver Diseases, Parasitic	KMT2C ROBO2	1.91e-03	9	219	2	C0023897
Disease	N-acylethanolamine-hydrolyzing acid amidase measurement	NAAA MYBPC1	1.91e-03	9	219	2	EFO_0008240
Disease	bacterial pneumonia (is_marker_for)	GRK2 MMP9	1.91e-03	9	219	2	DOID:874 (is_marker_for)
Disease	Lupus Erythematosus, Systemic	MECP2 PXK C1S C2	1.94e-03	71	219	4	C0024141
Disease	cholesteryl esters to total lipids in very small VLDL percentage	DMGDH COBLL1 GPAM PCIF1	1.94e-03	71	219	4	EFO_0022259
Disease	age at first birth measurement	TBC1D21 HSP90AA2P JADE2 LARS2 SIPA1L1	2.05e-03	120	219	5	EFO_0009101
Disease	migraine disorder, endometriosis	SBF2 RASGEF1C ROBO2 MAPK9	2.15e-03	73	219	4	EFO_0001065, MONDO_0005277
Disease	diet measurement	SKIDA1 LENG8 PARP1 NALF1 DSTYK BTN1A1 NGEF GPC5 POU2F3 ZNF714 PIGS TEX15 CCDC12 LARS2 FRK INF2 ROBO2	2.25e-03	1049	219	17	EFO_0008111
Disease	free cholesterol to total lipids in large LDL percentage	DMGDH COBLL1 GPAM PCIF1	2.26e-03	74	219	4	EFO_0022280
Disease	Prostatic Neoplasms	KMT2C SETDB1 PARP1 MMP9 HSP90AB1 COL5A1 JADE2 CALR CHD7 IGF2R ROBO2 EIF3A	2.32e-03	616	219	12	C0033578
Disease	Malignant neoplasm of prostate	KMT2C SETDB1 PARP1 MMP9 HSP90AB1 COL5A1 JADE2 CALR CHD7 IGF2R ROBO2 EIF3A	2.32e-03	616	219	12	C0376358
Disease	Ceroid lipofuscinosis, neuronal 1, infantile	RPS6KB1 PARP1	2.37e-03	10	219	2	C2931673
Disease	Inherited focal segmental glomerulosclerosis	MYO1E INF2	2.37e-03	10	219	2	cv:CN327126
Disease	Asthma, Occupational	HERC2 PRKCA	2.37e-03	10	219	2	C0264423
Disease	Focal segmental glomerulosclerosis	MYO1E INF2	2.37e-03	10	219	2	cv:C0017668
Disease	pleural tuberculosis (is_marker_for)	MMP9 CCL22	2.37e-03	10	219	2	DOID:106 (is_marker_for)
Disease	free cholesterol to total lipids in small VLDL percentage	PRAM1 DMGDH COBLL1 PCIF1	2.38e-03	75	219	4	EFO_0022287
Disease	CCL2 measurement	SETDB1 DSTYK FAM149A CDCP1 HIVEP3	2.54e-03	126	219	5	EFO_0004749
Disease	non-high density lipoprotein cholesterol measurement	USP34 PXK SCAF4 NR1I2 DSTYK C2 COBLL1 GPAM CHD7 FRK IGF2R PROX2 PCIF1	2.74e-03	713	219	13	EFO_0005689
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	COBLL1 GPAM IGF2R PCIF1	2.74e-03	78	219	4	EFO_0022187
Disease	glomerulosclerosis (implicated_via_orthology)	MMP9 INF2	2.89e-03	11	219	2	DOID:0050851 (implicated_via_orthology)
Disease	cocaine use	CYP11A1 CHRNA6	2.89e-03	11	219	2	C3496069
Disease	X-11315 measurement	LARS2 MROH6	2.89e-03	11	219	2	EFO_0021223
Disease	Hereditary Nephrotic Syndromes, Autosomal Dominant	MYO1E INF2	2.89e-03	11	219	2	cv:CN043612
Disease	Alzheimer's disease (is_marker_for)	PHACTR2 MMP9 DYNC1H1 HSP90AA1 AKR7A2 MAPK9 CDC42	3.20e-03	257	219	7	DOID:10652 (is_marker_for)
Disease	esophagus adenocarcinoma (is_marker_for)	CYP24A1 MMP9	3.45e-03	12	219	2	DOID:4914 (is_marker_for)
Disease	congestive heart failure (implicated_via_orthology)	RYR2 PARP1 MMP9	3.49e-03	41	219	3	DOID:6000 (implicated_via_orthology)
Disease	triglycerides in large LDL measurement	COBLL1 IGF2R PCIF1	4.00e-03	43	219	3	EFO_0022319
Disease	Familial idiopathic steroid-resistant nephrotic syndrome	MYO1E INF2	4.05e-03	13	219	2	cv:C4273714
Disease	bronchiolitis obliterans (is_marker_for)	MMP9 CCL22	4.05e-03	13	219	2	DOID:2799 (is_marker_for)
Disease	Charcot-Marie-Tooth disease type 4	FGD4 SBF2	4.05e-03	13	219	2	cv:C4082197
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	ABCA8 COBLL1 NR1H3 GPAM IGF2R PCIF1	4.51e-03	206	219	6	EFO_0004612, EFO_0020947
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	DMGDH COBLL1 NR1H3 GPAM IGF2R SIPA1L1 PCIF1	4.54e-03	274	219	7	EFO_0004530, EFO_0004612
Disease	QRS complex, QRS duration	HEATR5B SIPA1L1 PRKCA	4.55e-03	45	219	3	EFO_0005054, EFO_0005055
Disease	esophagus squamous cell carcinoma (is_implicated_in)	CYP24A1 KMT2C CALR	4.55e-03	45	219	3	DOID:3748 (is_implicated_in)
Disease	triglyceride measurement, phospholipid measurement	DMGDH COBLL1 NR1H3 GPAM PCIF1	4.77e-03	146	219	5	EFO_0004530, EFO_0004639
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	PCSK1 CYP11A1 MKI67 ABCC2 MMP9	4.90e-03	147	219	5	DOID:9352 (biomarker_via_orthology)
Disease	systemic lupus erythematosus (is_marker_for)	MKI67 C2 PRF1	5.14e-03	47	219	3	DOID:9074 (is_marker_for)
Disease	Alopecia, Male Pattern	PARP1 ABCC2	5.40e-03	15	219	2	C4083212
Disease	Androgenetic Alopecia	PARP1 ABCC2	5.40e-03	15	219	2	C0162311
Disease	Female pattern alopecia (disorder)	PARP1 ABCC2	5.40e-03	15	219	2	C0263477
Disease	Adenocarcinoma of large intestine	PTK7 GRK2 PRKCA MAPK9	5.76e-03	96	219	4	C1319315
Disease	lung adenocarcinoma (is_implicated_in)	CYP24A1 KMT2C CALR	5.78e-03	49	219	3	DOID:3910 (is_implicated_in)
Disease	susceptibility to measles measurement	MYO1E KIAA1671 XIRP2	5.78e-03	49	219	3	EFO_0008414
Disease	Seizures	CYP11A1 MECP2 CDKL5 GLDC MED12L ABCC2	5.91e-03	218	219	6	C0036572
Disease	eye colour measurement	MDGA2 CENPP DSTYK HERC2 SORBS2 ERCC6L2	5.91e-03	218	219	6	EFO_0009764
Disease	serum IgG glycosylation measurement	CWF19L2 CYP24A1 MDGA2 RYR2 UMODL1 SORBS1 SKI PROX2 ERCC6L2 ROBO2	5.97e-03	523	219	10	EFO_0005193
Disease	pulmonary fibrosis (biomarker_via_orthology)	MMP9 CCL22 HSP90AB1	6.12e-03	50	219	3	DOID:3770 (biomarker_via_orthology)
Disease	fourth ventricle volume measurement	CWF19L2 XIRP2	6.14e-03	16	219	2	EFO_0010303
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ABCA8 DMGDH COBLL1 NR1H3 GPAM IGF2R PCIF1	6.26e-03	291	219	7	EFO_0008317, EFO_0020946
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	PITPNM2 DMGDH COBLL1 GPAM IGF2R PCIF1	6.45e-03	222	219	6	EFO_0008317, EFO_0020943
Disease	transient cerebral ischemia (biomarker_via_orthology)	MECP2 PARP1 NFKB1 MMP9 ROBO2	6.45e-03	157	219	5	DOID:224 (biomarker_via_orthology)
Disease	Parkinson's disease (implicated_via_orthology)	RRN3P2 CALR ATP13A5 LRRK1 MAPK9	6.45e-03	157	219	5	DOID:14330 (implicated_via_orthology)
Disease	severe acute respiratory syndrome, COVID-19	LRTM1 LYST NALF1 GLDC EIF3L GPC5 SIPA1L2 ADAMTS12 PRKCA	6.46e-03	447	219	9	EFO_0000694, MONDO_0100096
Disease	Schizophrenia	TNIK NRIP1 CMYA5 ARHGEF11 CFAP65 SETDB1 ALDH3A1 MMP9 LARS2 ADAMTSL3 ADAMTS12 PRKCA DAAM2 CDC42	6.50e-03	883	219	14	C0036341

Protein segments in the cluster

Peptide	Gene	Start	Entry
EAPATSPRKLNLEWE	UMODL1	296	Q5DID0
VSWPATKESKDILAP	USP26	586	Q9BXU7
ANPWDGKSLKPDSVR	AKR7A2	106	O43488
RDKEICADPRVPWVK	CCL22	71	O00626
QKKLAEDSTWPPINR	ATP13A5	1161	Q4VNC0
KTQEKPPKELVNEWS	CHMP3	6	Q9Y3E7
KTDTSEKPKNQLWPE	CEP152	596	O94986
TLPLLVENADPEWKK	CEP152	1101	O94986
RWKESDEPFRPVQAK	C6orf62	131	Q9GZU0
KEILKNFPKERWDPS	CARNMT1	186	Q8N4J0
NFPKERWDPSKVNIL	CARNMT1	191	Q8N4J0
RQKLPEKTERFDSWP	BTN1A1	331	Q13410
PEEPKRKVDTSVSWE	AKAP12	666	Q02952
IIPQWKTSESPVREK	ADAM19	46	Q9H013
PDTKSKVYLRTPNWD	CDCP1	551	Q9H5V8
QKLPEWAADEPVEKT	ALDH3A1	76	P30838
APEEVTKSQPEKWDE	CT47B1	256	P0C2W7
KKTVPEEAWPNNKES	ALMS1	3441	Q8TCU4
AEKAQSAPDKDKWLP	ARHGEF11	496	O15085
DRDKNKPNDWTVPKG	GLCE	241	O94923
SVSWVVDPKPDSKRS	ANKS1A	1116	Q92625
ETERVERPPADDWKK	CHD7	941	Q9P2D1
ERPPADDWKKSESSR	CHD7	946	Q9P2D1
PAPWEEKSRVQKSFQ	CENPP	26	Q6IPU0
IVPPKSLEISKDWQS	COBLL1	736	Q53SF7
DVKRWLENKPSITPS	EFCAB12	121	Q6NXP0
SPQLDALKEKFPDWT	ERMP1	876	Q7Z2K6
PEDKDESNPVIWTKI	ADAMTS12	1166	P58397
SDPELVQWKKELRDA	GRK2	636	P25098
QEQFSPSPEKIKWAE	CLYBL	281	Q8N0X4
PTEDLRSWEKKQRAP	NKD1	216	Q969G9
AKREDWPKIERNELP	IQCM	371	A0A1B0GVH7
QTPNRKEWVTPKEFR	PARP1	326	P09874
WSKQRTKERESPAPE	KCTD19	731	Q17RG1
QDKKLPPLLSEIWDV	NR1H3	431	Q13133
SSPDDAVIWRGPKKN	NUBP1	136	P53384
PESPLWEKIRDNENR	RBL2	601	Q08999
KEQEDPNKLATSWPD	DAAM2	86	Q86T65
IADKWPALPRKLDSV	MMP9	556	P14780
PDWIFPSESERDKIK	MAPK9	276	P45984
RESWDSAKKLPPVQE	ELOA2	421	Q8IYF1
ELNKTKPIWTRNPDD	HSP90AB1	281	P08238
KSEQWVKETPLPARR	KLHL36	321	Q8N4N3
ESPDTWKGKDLLRIP	LRTM1	211	Q9HBL6
RPRPTWEEVKKQLEN	FAM133A	36	Q8N9E0
LPWRNQPSNKKDIDD	KMT2C	161	Q8NEZ4
KKRQAPDPNLEWTQI	MED12L	176	Q86YW9
KQREEPQDWPLNEKR	MAGEC3	121	Q8TD91
NDQSPWEEKAKLDPE	KIAA1671	381	Q9BY89
RSDEPSPQWLKELKS	KIAA1671	1781	Q9BY89
RKKQAWVSPRRPDEE	JSRP1	301	Q96MG2
DSEPKNVEPEKNESW	NUDT15	106	Q9NV35
ETRLKAQPWLFDAPK	NUDT22	46	Q9BRQ3
DECLEQKPAQPGRKW	FAM149A	421	A5PLN7
WENKDLRESPAQAPK	GPR179	1876	Q6PRD1
KIIQRFPQKDWDDTP	SBF2	26	Q86WG5
ECWDTKPEKRPLALS	LRRK1	1501	Q38SD2
WKPAPKEDDRRTSAI	NAAA	291	Q02083
VQLLQGRSPKPDKWE	GPC5	466	P78333
KLTERFFKNTPWPEA	EIF3L	101	Q9Y262
RLEEKTDLKLPPANW	EDRF1	66	Q3B7T1
DIEDRLSPNPWQEKR	HERC2	3456	O95714
TDILKDPSKFPNVTW	LRRC75A	251	Q8NAA5
LEKRLTNESWQPPIE	LRRC53	496	A6NM62
RPASWKLQTPKEEVS	CFAP65	1586	Q6ZU64
ERTPWHVTIKPKSQE	C2	476	P06681
EPVAESPKKKRWEAA	LENG8	346	Q96PV6
PPWDIRIKFQKASVS	IL12RB2	226	Q99665
VKVWDPRQKDDPVAN	DNAAF10	141	Q96MX6
WPRQNEKKPSEVFRT	JADE2	41	Q9NQC1
IRDAPWTLTPEFLEK	PCYT1B	146	Q9Y5K3
TDESTPAKKTDIPWR	FHIP2B	41	Q86V87
RNDWKVGLDVTPKPT	PRF1	126	P14222
EAVPSQTPDKEKAWK	CWF19L2	121	Q2TBE0
AGRKPWERSNSVEKP	EVL	321	Q9UI08
PSLQIEEPEWEKRRS	FAM234B	356	A2RU67
LPPDSLDWNDAKKSL	FGD4	366	Q96M96
ETFRTDKKPDPANWE	NRDE2	161	Q9H7Z3
RISAPTPEEKEEWIK	CYTH1	356	Q15438
NWEELLARKVEPPFK	RPS6KB1	356	P23443
SLLNTWDPKVPDVDI	NRIP1	466	P48552
LEWQEKPKPASVDAN	MED25	406	Q71SY5
QNRKLDPCISWKDEP	TUBGCP5	196	Q96RT8
TKVENEAPWVTDKRP	ABCC2	1276	Q92887
KSWEVKPEAEPQTQA	MROH6	46	A6NGR9
SPSSFENVKEKWVPE	CDC42	86	P60953
KKWPRTPKEEAQSLE	MKI67	1086	P46013
RWPQTPKEKAQALED	MKI67	2301	P46013
RADKPWARLTPADKA	PHACTR2	591	O75167
WRVDEVEQSPKPKRQ	NPIPB7	366	O75200
PSREEAAKWSQVRKD	NR1I2	191	O75469
EVSVFTPSKPREKWQ	PITPNM2	976	Q9BZ72
KEAKPAVWLNSVPTR	KIZ	521	Q2M2Z5
KPLLEKWLNDAESSP	POU2F3	246	Q9UKI9
SPPAITLEWKRKVAQ	DSTYK	556	Q6XUX3
WAALKEKLGPQDSDP	INF2	11	Q27J81
PKPIILWSRADKEVA	MDGA2	471	Q7Z553
WNDVDPPKDTIVKNI	NDUFS2	66	O75306
RTAKVWTPEDPRKLN	PTF1A	296	Q7RTS3
WTPEDPRKLNSKSSF	PTF1A	301	Q7RTS3
STWEKPDDLKTPAEQ	PRPF40A	166	O75400
VSAGRDSDPSWKKPI	PROX2	556	Q3B8N5
EWDLTVSKPLNVELP	PORCN	281	Q9H237
PVKWTAPEAIRSNKF	FRK	396	P42685
ETLRVPADKIWKPDI	CHRNA6	106	Q15825
LGEEDKSKPFVAPRW	HEATR5B	1231	Q9P2D3
LAKWAAESKLDPNDP	CC2D2A	851	Q9P2K1
AKWAPTPERLQELSA	PCIF1	651	Q9H4Z3
IKDKPVQIRPWNLSD	CPEB2	411	Q7Z5Q1
RPRPTWEEVKEQLEK	FAM133B	36	Q5BKY9
RPERWLQEKEKINPF	CYP24A1	436	Q07973
KDKPVQIRPWNLSDS	CPEB3	521	Q8NE35
KEKAREESWGPPRES	EIF3A	1181	Q14152
KRPDVITKTDWLAPV	GLT6D1	41	Q7Z4J2
IKEEKFLSWVQSEPP	DYTN	191	A2CJ06
ESPKAASDIWKPVLS	CHAMP1	506	Q96JM3
WETLPPHEKQRRKDE	GALNT6	331	Q8NCL4
LQEKGLPPKRWEAED	FUT10	401	Q6P4F1
IAPPSKWNISIFKEE	CMYA5	2351	Q8N3K9
PDASKPEDWDERAKI	CALR	211	P27797
KEDTPNSVWEPAKAK	C1S	296	P09871
KSEGARITSWPKENP	COL5A1	1686	P20908
DPENFDPTRWLSKDK	CYP11A1	431	P05108
PGKPWRTEQTEDLKR	CPPED1	96	Q9BRF8
TWDLKPVREITFPKS	LYST	3736	Q99698
EKPPLSAETQWKDRA	DMGDH	36	Q9UI17
WEKTKPVTGNLRPEE	DYNC1H1	1261	Q14204
IKDKPVQIRPWNLSD	CPEB4	551	Q17RY0
VLKDLDRLPTETWPQ	ERMARD	496	Q5T6L9
SAAELPWAVKPEDKA	EPS15	116	P42566
DIPQWNSDKPSLKDI	IDS	471	P22304
NKTKPIWTRNPDDIT	HSP90AA1	291	P07900
EVDLANLAPRKPDWD	CCDC12	101	Q8WUD4
NLAPRKPDWDLKRDV	CCDC12	106	Q8WUD4
RTWPTILDTDDIPKK	DIP2A	1121	Q14689
APFKRREEPATSLWK	ERCC6L2	1521	Q5T890
PGKVVWKRPQDICDD	CAPN6	46	Q9Y6Q1
SRPKEWRPEKISDLQ	CDKL5	816	O76039
DQLSVRWVSPPALKD	CRLF1	251	O75462
LDSDTLNPDWKGIPK	SCAF4	621	O95104
RAKWLKEPNPEAEEL	RYR2	3381	Q92736
PVDQKPEEKARESSW	METTL8	116	Q9H825
KRWRVDEVEQSPKPK	NPIPB6	361	E9PJ23
DEWFSRGKKPIEDPA	CTNND1	626	O60716
QEPKALVSEWKEPQA	DDB1	481	Q16531
KTKPIWTRNPDDITN	HSP90AA2P	291	Q14568
VQLDLQDLSKKPPDW	MCOLN2	191	Q8IZK6
WRVDEVEQSPKPKRQ	NPIPB9	381	F8W1W9
DKPWPSLLDKEREES	NKAP	111	Q8N5F7
NPWKDRTKAEEPSDL	NKAP	276	Q8N5F7
TVPVVDPDKDDQNWK	SLC8B1	341	Q6J4K2
DDPTLPEGWTRKLKQ	MECP2	96	P51608
DHLPEDKWSAEKRRP	PIGS	206	Q96S52
SVWKPEVNPDIKSEF	MIDN	451	Q504T8
KLEVKVWDPNSPLTD	MTA3	176	Q9BTC8
TQTEELKNWKPARPV	IGF2R	991	P11717
LWKKQRVDEPLVDPE	FAM47E	311	Q6ZV65
EIIKNTDSWAPPLEI	DROSHA	336	Q9NRR4
WEPPKTKLDEDLESS	DROSHA	466	Q9NRR4
ETFPRDPEKAVVWAK	SEL1L3	851	Q68CR1
EVPLWLDRKESAVPT	SEZ6L	181	Q9BYH1
VKRKPPIDKTEWDSF	TBC1D21	21	Q8IYX1
PPEKDILWDVKTDAL	LARS2	671	Q15031
IFAPSPQSRDLWVKK	TEC	91	P42680
KIERISSWKTPPQEN	TCP10L	171	Q8TDR4
DWEKLENREIQPPFK	PRKCA	601	P17252
APPRLSQDWLAVKEA	LRRC56	241	Q8IYG6
KDREELSPTFWDPKV	PIWIL2	111	Q8TC59
LAEQQWDKKLPEPLS	GPAM	671	Q9HCL2
WNTDNEPAKVKPELL	NGEF	21	Q8N5V2
QTPLWKPQSSEPKRD	PRAM1	251	Q96QH2
PDLKSSVKAESPAEW	SKIDA1	506	Q1XH10
DWELPAKREAQQPLK	SGSM3	716	Q96HU1
REARAPLKSWSQEDK	SPATA32	301	Q96LK8
ADWPPRKENIKESSR	SIPA1L1	81	O43166
VRARVSEWPPKKDCS	SIPA1L2	76	Q9P2F8
DRWKFFEETSKPVPQ	SHROOM2	796	Q13796
LTSEKRAPDLQDLPW	PROZ	176	P22891
SEKSAEPLSKPWLED	IMPG2	621	Q9BZV3
ETLKLPPRSIKWNVD	PARVA	166	Q9NVD7
EDPSAVALKEPWQEK	PI4KB	526	Q9UBF8
PSEKDKPSSWLRTLA	SKI	346	P12755
KEDSAWEPQKKVPRS	SRBD1	36	Q8N5C6
SSTEKHDWDPPDRKV	SORBS2	186	O94875
PSSEETPKNKVASWL	SETDB1	971	Q15047
DFDPSVKWKLLPQEE	ABCA8	1606	O94911
PKFDKIPWLSEASLV	C1orf105	11	O95561
NDKKPEEWDERAKIP	CLGN	271	O14967
RWKESKQPDAIPGDI	XIRP2	1706	A4UGR9
WVPAEKPIENRDFLK	TNMD	156	Q9H2S6
PLILSDDPTSKREQW	TSGA13	161	Q96PP4
WKPKDVKESLAREVP	ZIM3	91	Q96PE6
SPSEKPAWAKEVEER	TNIK	526	Q9UKE5
KQDPITSLEQEKEPW	ZNF714	21	Q96N38
LPDWFQTAKTEPKDA	TJP2	751	Q9UDY2
LKSFRTSPWDPKENL	TSR1	506	Q2NL82
RDPQHDLDRVKKPEW	UQCRFS1	196	P47985
AVGWAPQRLVDPKSK	TSPYL2	151	Q9H2G4
RDLPDPLDQKVVTWE	TRPM5	1041	Q9NZQ8
PENQTEKERWKALRS	RASGEF1C	446	Q8N431
GRKLEKPNPEKNAWE	PSTK	206	Q8IV42
SRDIWAKIPSKDDPK	TECPR1	171	Q7Z6L1
TPAELPWTNIDLKEA	TECPR1	481	Q7Z6L1
SERNDWEPPDKKVDT	SORBS1	511	Q9BX66
KEPEKTEEFQWPQRS	HIVEP3	876	Q5T1R4
RTQWPSPEEYDKLAK	ZHX1	681	Q9UKY1
RKQAEKEVPWSPSAE	PRRC2B	546	Q5JSZ5
RSEPKWEVVEPLKDI	PXK	141	Q7Z7A4
PLKWLPVQESSTDDK	SPCS1	141	Q9Y6A9
DPQPTVRWKKDDADL	ROBO2	251	Q9HCK4
EAPKPKRKVEVWEQS	YJU2	236	Q9BW85
EAFLEPLWKKLQDPS	RRN3P2	266	A6NIE6
LPPIKELNEEWKENS	nan	501	Q6ZUG5
KPDVITLLEQEKEPW	ZNF780A	51	O75290
KPDVITLLEQEKEPW	ZNF780B	51	Q9Y6R6
DPGQWPSKEALKLDD	ZNFX1	586	Q9P2E3
SRTKWLKPPAENKAE	RELT	401	Q969Z4
NRTLKDKADPEGVWP	WDR93	396	Q6P2C0
EKSEAPTIGNARPWK	ZGRF1	1676	Q86YA3
KKNSDDAPWSPKARV	PHF8	871	Q9UPP1
RLWIAATAKKPSPQE	TRIP4	466	Q15650
KKEEEELRRTAPSPW	USP34	501	Q70CQ2
NLEVKWTDPIERPKQ	TEX15	1296	Q9BXT5
AFTEWIEPPKRERKA	SMARCA5	726	O60264
VPSWLKKPQDSQLEE	PTK7	411	Q13308
KPTIKWERADGSSLP	PTK7	531	Q13308
EWPKRKVLQDLVPDD	ZNF512	361	Q96ME7
KQDPDTWENELPVSK	USP13	176	Q92995
LSKPKAPATLLEEWD	THEG	271	Q9P2T0
GEVWTKKAPRRPQSD	ZAR1	226	Q86SH2
SPVEAKLPWLKQAQE	ADAMTSL3	541	P82987
VKPENKFWPTIARID	GLDC	976	P23378
CIKPNETKKPRDWEE	MYO1E	586	Q12965
KIWLAAPRENEKPFI	NALF1	16	B1AL88
KPNETKRPRDWEENR	MYO1F	586	O00160
PDPEEVWKSAELLKD	MYO5A	16	Q9Y4I1
PPEVSWLKNEKALAS	MYOM1	1601	P52179
PQVDVWELLKNAKPS	MYBPC1	206	Q00872
DLADPRTWRSVPEKK	PCSK1	451	P29120
KLLEIPDPDKNWATL	NFKB1	821	P19838
WKTDVILDRKKNPEP	NMES1	36	Q9C002
ILDRKKNPEPWETVD	NMES1	41	Q9C002